ANN HATFIELD: Open Payments
NPI 1780217638 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,683 in 74 payments from 32 companies in 2025. Trend: 2023 $1,171 · 2024 $1,823 · 2025 $1,683
Food & beverage: $1,683
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $215 |
| Daiichi Sankyo Inc. | 5 | $158 |
| AstraZeneca Pharmaceuticals LP | 6 | $149 |
| BeOne Medicines USA, Inc. | 7 | $126 |
| E.R. Squibb & Sons, L.L.C. | 6 | $109 |
| Janssen Scientific Affairs, LLC | 1 | $99 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $70 |
| PFIZER INC. | 3 | $67 |
| Incyte Corporation | 3 | $67 |
| Blueprint Medicines Corporation | 2 | $53 |
Products named: Enhertu, ERLEADA, OPDIVO, Fabhalta, BRUKINSA, TEVIMBRA, JAKAFI, DATROWAY.
Industry payments across AL — which companies pay providers there.
